Obesity may account for up to one in four polypharmacy cases

Post author:admin
Post published:July 1, 2026
Post category:uncategorized

The study reveals obesity’s role in polypharmacy, indicating that reducing obesity may lower medication burden and enhance quality of life for older adults.

Empowering individuals with knowledge, fostering healthier lifestyles, and fostering a community dedicated to diabetes awareness and prevention. Together, we’re shaping a healthier future.

Helpful Links

Subscribe To Us

By submitting via this part of the website you are granting us permission to store and process your data according to our Standard privacy policy

UPCOMING EVENTS

You Might Also Like

Twice-yearly blood pressure treatment could reshape hypertension care, but doctors warn against a “fire-and-forget” approach

ASDP responds to NDIS reform direction, calls for functional approach and strong developmental supports

Systematic review identifies stress-induced biological triggers in oncology

Helpful Links

Subscribe To Us